RMDN3 and amyotrophic lateral sclerosis: Strikingly, it was orchestrated by fused in sarcoma (FUS) protein, and not by directly altering PTPIP51- VAPB expression, but by activating glycogen synthase kinase 3-beta (GSK-3b), evidencing a correlation between this molecule and ALS.